Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers

Gurkan E., TARKUN İ., ŞAHİN T., Cetinarslan B., CANTÜRK Z.

DIABETES RESEARCH AND CLINICAL PRACTICE, vol.106, no.3, pp.567-575, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 106 Issue: 3
  • Publication Date: 2014
  • Doi Number: 10.1016/j.diabres.2014.09.046
  • Journal Name: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.567-575
  • Keywords: Cardiovascular disease, Type 2 diabetes, Insulin analogues, Exenatide, GLUCAGON-LIKE PEPTIDE-1, TYPE-2 DIABETIC-PATIENTS, C-REACTIVE PROTEIN, METABOLIC SYNDROME, RANDOMIZED-TRIAL, GLP-1 ANALOG, IN-VIVO, RESISTANCE, LIRAGLUTIDE, METFORMIN
  • Kocaeli University Affiliated: Yes

Abstract

Aims: To demonstrate the efficacy of exenatide versus insulin glargine on endothelial functions and cardiovascular risk markers.